Uber To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Keybanc boosted the price target for Uber Technologies, Inc. UBER from $70 to $79. Keybanc analyst Justin Patterson maintained an Overweight rating. Uber shares gained 1.4% to close at $68.99 on Monday. See how other analysts view this stock.
Telsey Advisory Group raised Costco Wholesale Corporation COST price target from $700 to $750. Telsey Advisory Group analyst Joseph Feldman maintained an Outperform rating. Costco shares rose 0.2% to close at $711.16 on Monday. See how other analysts view this stock.
Piper Sandler cut the price target for Chegg, Inc. CHGG from $9 to $8.5. Piper Sandler analyst Arvind Ramnani downgraded the stock from Neutral to Underweight. Chegg shares fell 2.8% to close at $9.30 on Monday. See how other analysts view this stock.
Jefferies increased Palantir Technologies Inc. PLTR price target from $13 to $22. Jefferies analyst Brent Thill upgraded the stock from Underperform to Hold. Palantir Technologies shares fell 1.8% to close at $16.72 on Monday. See how other analysts view this stock.
Deutsche Bank slashed the price target for Li Auto Inc. LI from $45 to $41. Deutsche Bank analyst Edison Yu upgraded the stock from Hold to Buy. Li Auto shares fell 1.2% to close at $28.00 on Monday. See how other analysts view this stock.
Stifel boosted the price target for Saia, Inc. SAIA from $484 to $526. Stifel analyst J. Bruce Chan downgraded the stock from Buy to Hold. Saia shares fell 0.5% to close at $531.75 on Monday. See how other analysts view this stock.
Barclays raised Church & Dwight Co., Inc. CHD price target from $76 to $80 Barclays analyst Lauren Lieberman maintained an Underweight rating. Church & Dwight shares rose 0.8% to close at $100.18 on Monday. See how other analysts view this stock.
Redburn Atlantic cut Bristol-Myers Squibb Company BMY price target from $77 to $54. Redburn Atlantic analyst Steve Chesney downgraded the stock from Buy to Neutral. Bristol-Myers Squibb shares fell 1.5% to close at $47.98 on Monday. See how other analysts view this stock.
HC Wainwright & Co. boosted Vertex Pharmaceuticals Incorporated VRTX price target from $397 to $457. HC Wainwright & Co. analyst Andrew Fein maintained a Buy rating. Vertex Pharmaceuticals shares rose 1% to close at $428.89 on Monday. See how other analysts view this stock.
RBC Capital boosted Catalent, Inc. CTLT price target from $58 to $63.5. RBC Capital analyst Sean Dodge downgraded the stock from Outperform to Sector Perform. Catalent shares rose 9.7% to close at $59.82 on Monday. See how other analysts view this stock.